Forum Discussion

CarolynPalmer-1's avatar
CarolynPalmer-1
Community Member
4 years ago

Login required when sharing link

Hoping some of you might be able to help with a problem we are encountering. Multiple people I have shared a “share” link with aren’t able to access the course and it is asking them for an articulate login. Thoughts? It is working for some and not for others. 

  • Hi Carolyn! Happy to help! If the other users already have existing Articulate IDs then they will be asked to login.  

  • MeghanKaskoun's avatar
    MeghanKaskoun
    Community Member

    we're experiencing this also, however no module is showing up once we login.  what would cause that?

     

    • Chris-Santos's avatar
      Chris-Santos
      Staff

      HI Meghan,

      Thank you for reaching out to our support!  It looks like the issue might be specific to your network based on my colleague's findings.  Feel free to respond back to Lejan if you need to continue working with him on this share link issue.

  • My team is having the same issues. My SMEs are being directed to the Articulate login screen for lessons that they need to review. PLEASE help.

    • KarlMuller's avatar
      KarlMuller
      Community Member

      Hi Herschel,

      Check the box: Allow users without Articulate ID to comment

       

      • HerschelThach-d's avatar
        HerschelThach-d
        Community Member

        It is checked
        [cid:image001.jpg@01D99566.6F8A2EB0]

        This e-mail message and any attachments, if any, may contain confidential or proprietary information of the AnovoRx family of companies and are intended solely for authorized use by the intended recipient(s) only. If you are not the intended recipient, you are hereby notified that any retention, disclosure, printing, copying, forwarding, distribution, or the taking of any action in reliance on the contents of this email, its contents and/or any attachments thereto is strictly prohibited. If you have received this e-mail message in error, please immediately notify the sender by reply message and then permanently delete this email, and any attachments thereto, from your system immediately. AnovoRx refers to AnovoRx Group, LLC, AnovoRx Distribution, LLC, AnovoRx Manufacturer Services, LLC and AnovoRx Holdings, Inc.

    • StevenBenassi's avatar
      StevenBenassi
      Staff

      Hi Herschel,

      Sorry to hear you've also hit this snag that's preventing your SMEs from being able to access shared Review links! I'd be happy to help you get this sorted out!

      As an initial troubleshooting step, we would recommend confirming with your network administrator that port 443 is open and the domains in the following article have been added to your organization's allowlist. This helps to ensure that your Articulate 360 applications will function properly.:

      Also, I'd suggest those who are affected by this issue clear the cache of their browser to see if that improves behavior. If you need help, this article explains how to do that:

      Hope this helps! Please let me know if you have any more questions!

      • HerschelThach-d's avatar
        HerschelThach-d
        Community Member

        Thanks. We will give it a try...next week.
        Have a GREAT weekend :)
        Hersh

        This e-mail message and any attachments, if any, may contain confidential or proprietary information of the AnovoRx family of companies and are intended solely for authorized use by the intended recipient(s) only. If you are not the intended recipient, you are hereby notified that any retention, disclosure, printing, copying, forwarding, distribution, or the taking of any action in reliance on the contents of this email, its contents and/or any attachments thereto is strictly prohibited. If you have received this e-mail message in error, please immediately notify the sender by reply message and then permanently delete this email, and any attachments thereto, from your system immediately. AnovoRx refers to AnovoRx Group, LLC, AnovoRx Distribution, LLC, AnovoRx Manufacturer Services, LLC and AnovoRx Holdings, Inc.